Grading the Range of Hepatic Encephalopathy From Overt to Covert: Animals to the Rescue!

Hepatology - United States
doi 10.1002/hep.29186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Covert Hepatic Encephalopathy-Silent but Serious

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Hepatic Encephalopathy: From the Pathogenesis to the New Treatments

ISRN Hepatology
2014English

Editorial: Covert Hepatic Encephalopathy-Silent but Serious. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

L-Ornithine L-Aspartate in Bouts of Overt Hepatic Encephalopathy

Hepatology
MedicineHepatology
2017English

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

PWE-153 Cost Effectiveness of Rifaximin-A in the Reduction of Recurrence of Overt Hepatic Encephalopathy

Gut
Gastroenterology
2014English

Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction

ASN Neuro
NeuroscienceNeurology
2018English

Overt and Covert Institutionalization in Europe

2001English

Overt Hepatic Encephalopathy Impairs Learning on the Encephalapp Stroop Which Is Reversible After Liver Transplant

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy